References
- Rodrigues CEM, Carvalho JF, Shoenfeld Y. Neurological manifestations of antiphospholipid syndrome. Eur J Clin Invest. 2010;40(4):350–359. doi: 10.1111/j.1365-2362.2010.02263.x.
- Ricarte IF, Dutra LA, Abrantes FF, et al. Neurologic manifestations of antiphospholipid syndrome. Lupus. 2018;27(9):1404–1414. doi: 10.1177/0961203318776110.
- Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Centralnervous system involvement in the antiphospholipid (hughes) syndrome. Rheumatology (Oxford). 2003;42(2):200–213. doi: 10.1093/rheumatology/keg080.
- Kesler A, Ellis MH, Reshef T, et al. Idiopathic intracranial hypertensionand anticardiolipin antibodies. J Neurol Neurosurg Psychiatry. 2000;68(3):379–380. doi: 10.1136/jnnp.68.3.379.
- Martín-Suñé N, Ríos-Blanco JJ, Noval-Martín S, et al. Case report intracranial hypertension and antiphospholipid antibodies. Int J Clin Rheumatol. 2013;8(1):9–11. doi: 10.2217/ijr.12.70.
- Singh R, Kumar A, Singh V, et al. Pseudotumor cerebri syndrome (PTCS), Clinico-Radiological profile: a prospective study. Neurol India. 2022;70(1):102–107.
- Leker RR, Steiner I. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol. 1998;55(6):817–820. doi: 10.1001/archneur.55.6.817.
- Markey KA, Mollan SP, Jensen RH, et al. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15(1):78–91. doi: 10.1016/S1474-4422(15)00298-7.
- Man YL, Sanna G. Neuropsychiatric manifestations of antiphospholipid syndrome—a narrative review. Brain Sci. 2022;12(1):1–15.
- Orefice G, De Joanna G, Coppola M, et al. Benign intracranialhypertension: a non-thrombotic complication of the primary antiphospholipidsyndrome? Lupus. 1995;4(4):324–326. doi: 10.1177/096120339500400417.
- Rudich DS, Yun SH, Liebling A, et al. Antiphospholipid antibody syndrome: raised intracranial pressure without CerebralVenous sinus thrombosis. J Neuroophthalmol. 2015;35(4):396–399. doi: 10.1097/WNO.0000000000000277.